• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24110 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Open magnetic resonance imaging (MRI) scanners
2007     HAYES, Inc. Open malabsorptive bariatric Surgery: roux-en-y gastric bypass
2020     National Institute for Health and Care Excellence (NICE) Open prenatal repair for open neural tube defects in the fetus. NICE interventional procedures guidance 668
2015     National Institute for Health and Care Excellence (NICE) Open reduction of slipped capital femoral epiphysis. NICE interventional procedures guidance 511
2007     HAYES, Inc. Open restrictive bariatric surgery: gastroplasty and gastric banding
2017     HAYES, Inc. Open sacroiliac joint fusion for unspecified sacroiliac joint dysfunction
2014     HAYES, Inc. Open surgery for sacroiliac joint fusion for the treatment of low back pain
2020     NIHR Health Technology Assessment programme Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT
2010     NIHR Health Technology Assessment programme Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03B/oil-in-water emulsion- adjuvanted (AS03B) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age
2010     Quality Improvement Scotland (NHS QIS ) Open, laparoscopic and robot-assisted laparoscopic radical prostatectomy for localised prostate cancer
2013     Scottish Health Technologies Group (SHTG) Open, laparoscopic and robot-assisted laparoscopic radical prostatectomy for localised prostate cancer.
2012     Institute for Clinical Evaluative Sciences (ICES) Opening eyes, opening minds: the Ontario burden of mental illness and addictions report
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid management practices for the prevention of drug diversion and misuse: a review of the clinical evidence and guidelines
2021     Penn Medicine Center for Evidence-based Practice (CEP) Opioid pain assessment
2020     Agency for Healthcare Research and Quality (AHRQ) Opioid treatments for chronic pain
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid trial periods for management of chronic non-cancer pain: a review of clinical effectiveness, guidelines and recommendations
2003     WorkSafeBC Opioid use in chronic non-cancer pain: proposal for a common approach across Canada
2014     Penn Medicine Center for Evidence-based Practice (CEP) Opioid-induced sedation scales
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Opioid-sparing effects of IV acetaminophen for patients undergoing surgery
2015     NIHR Health Technology Assessment programme Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness
2021     Penn Medicine Center for Evidence-based Practice (CEP) Opioids for vaso-occlusive crisis in pregnant patients
2007     Adelaide Health Technology Assessment (AHTA) Opportunistic screening of asymptomatic individuals for Chlamydia
2025     NIHR Health and Social Care Delivery Program Opportunities and practices supporting responsive health care for forced migrants: lessons from transnational practice and a mixed-methods systematic review
2014     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Opportunities and strategies to drive appropriate use of MRI in Austria
2009     Technology Assessment Unit of the McGill University Health Centre (MUHC) Opportunity costs associated with technology expansion in the MUHC
1999     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Opportunity of a screening program for genetic hemochromatosis
1995     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Opportunity of a screening program of Hemochromatosis in France
1999     L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES) Opportunity of a screening programme for deafness in the newborn
2003     Medical Services Advisory Committee (MSAC) Optical biometry using partial coherence interferometry prior to cataract surgery
2008     Medical Services Advisory Committee (MSAC) Optical coherence tomography
2016     HAYES, Inc. Optical Coherence Tomography (OCT) for plaque characterization and stent implantation
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
2015     Medical Services Advisory Committee (MSAC) Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
2009     Medical Advisory Secretariat (MAS) Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis
2011     HAYES, Inc. Optical coherence tomography for coronary artery plaque characterization and stent evaluation
2003     Alberta Heritage Foundation for Medical Research (AHFMR) Optical coherence tomography for diagnosing retinal disease
2008     Adelaide Health Technology Assessment (AHTA) Optical coherence tomography for MS prognosis
2002     NIHR Horizon Scanning Centre (NIHR HSC) Optical coherence tomography for the diagnosis of eye disorders - horizon scanning review
2014     NIHR Health Technology Assessment programme Optical coherence tomography for the diagnosis, monitoring and guiding of treatment for neovascular age-related macular degeneration: a systematic review and economic evaluation
2014     Health Quality Ontario (HQO) Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: an evidence-based analysis
2014     Health Quality Ontario (HQO) Optical coherence tomography monitoring strategies for A-VEGF–treated age-related macular degeneration: OHTAC recommendation
2007     Haute Autorite de sante (HAS) Optical coherence tomography of the posterior pole of the eye
2014     National Institute for Health and Care Excellence (NICE) Optical coherence tomography to guide percutaneous coronary intervention. NICE interventional procedures guidance 481
2013     Medical Services Advisory Committee (MSAC) Optical coherence tomography, for the diagnosis and monitoring of treatment effectiveness with aflibercept in patients with central retinal vein occlusion (co-dependent)
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Optical coherence tomography. Systematic review
2003     VA Technology Assessment Program (VATAP) Optical devices for adults with low vision: a systematic review of published studies of effectiveness
2000     VA Technology Assessment Program (VATAP) Optical lens fabrication systems
2022     National Institute for Health and Care Excellence (NICE) Optilume for treating recurrent bulbar urethral strictures. NICE medical technologies guidance 73
2016     NIHR Health Technology Assessment programme OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
2016     NIHR Health Technology Assessment programme OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal care of chronic, non-healing, lower extremity wounds: a review of clinical evidence and guidelines
2007     Medical Advisory Secretariat (MAS) Optimal health system design for preventive health screening
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal in-hospital umbilical cord care for newborns: clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal method for driving assessment in older adults and in patients who have had a cerebrovascular accident: clinical evidence, cost-effectiveness, and guidelines
2017     NIHR Health Services and Delivery Research programme Optimal NHS service delivery to care homes: a realist evaluation of the features and mechanisms that support effective working for the continuing care of older people in residential settings
2013     Health Quality Ontario (HQO) Optimal onset-to-admission interval for inpatient stroke rehabilitation: a rapid review
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pharmacotherapy for transplant ineligible multiple myeloma
2022     NIHR Health Technology Assessment programme Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal pre-operative testing and assessment for adult patients undergoing elective surgical procedures: a review of the clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal screening procedures prior to physician visits: guidelines
2014     NIHR Health Technology Assessment programme Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment -systematic review and modelling of progression and cost-effectiveness
2015     NIHR Health Technology Assessment programme Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling
2018     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal strategies for the diagnosis of acute pulmonary embolism: a health technology assessment
2021     NIHR Health Technology Assessment programme Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model
2003     VA Technology Assessment Program (VATAP) Optimal temperature for cardioplegia during coronary artery bypass grafting: a systematic review of published randomized controlled trials for myocardial protection
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal timing and frequency of follow-up care for patients receiving at-home supplemental oxygen: clinical evidence and guidelines
2013     Health Quality Ontario (HQO) Optimal timing for antibiotic administration in patients with community-acquired pneumonia: a rapid review
2013     Health Quality Ontario (HQO) Optimal timing of hip fracture surgery: a rapid review
2013     Health Quality Ontario (HQO) Optimal timing to begin an active rehabilitation program after a hip fracture: a rapid review
2019     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimal use of minimally invasive glaucoma surgery: a health technology assessment
2025     NIHR Health Services and Delivery Research programme Optimisation of the deployment of automated external defibrillators in public places in England
2020     NIHR Health Services and Delivery Research programme Optimising acute care for people with dementia: a mixed-methods study
2025     NIHR Health and Social Care Delivery Program Optimising neonatal services for very preterm births between 27+0 and 31+6 weeks gestation in England: the OPTI-PREM mixed-methods study
1996     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Optimization of diagnosis of fertility disorders - primary research
1996     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Optimization of diagnostic management of suspected lung embolism - primary research
2013     Health Quality Ontario (HQO) Optimized timing of thrombolytic therapy for the treatment of stroke: a rapid review
2014     NIHR Horizon Scanning Centre (NIHR HSC) OPTIMIZER™ system for chronic heart failure
2015     Institute of Health Economics (IHE) Optimizing adoption and diffusion of medical devices at the system level
2013     Health Quality Ontario (HQO) Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework
2013     Health Quality Ontario (HQO) Optimizing chronic disease management mega-analysis: economic evaluation
2023     Institute of Health Economics (IHE) Optimizing MRI service capacity: review of the relationship between MRI delay and outcomes
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Optimizing the implementation of diagnostic imaging decision support tools: a review of the evidence and guidelines
2022     Institute of Health Economics (IHE) Optimizing the use of low back pain and spine condition-related interventions and procedures
2021     Institute of Health Economics (IHE) Optimizing vascular risk reduction initiatives in Alberta: a clinical review and economic analysis
2006     Medical Advisory Secretariat (MAS) Optimum methadone compliance testing: an evidence-based analysis
2002     Centre for Clinical Effectiveness (CCE) Optimum number of consecutive nights for shift workers
2014     Agency for Healthcare Research and Quality (AHRQ) Options for developing a web-based forum on patient registries
2001     University HealthSystem Consortium (UHC) Options for osteoporosis
2018     NIHR Health Technology Assessment programme Options for possible changes to the blood donation service: health economics modelling
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Options to identify inappropriate use of MRI, Part 3
2006     NIHR Horizon Scanning Centre (NIHR HSC) Optiscope for internal examinations and surgical operations: horizon scanning technology note
2011     HAYES, Inc. OptiVol fluid status monitoring system (Medtronic Inc.) for management of heart failure
2000     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices for the detection of cervical cancer - horizon scanning review
2002     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic devices in screening for cervical cancer - horizon scanning review
2003     NIHR Horizon Scanning Centre (NIHR HSC) Opto-electronic low vision aids for the visually impaired - horizon scanning review
2023     Agency for Care Effectiveness (ACE) Optune for the treatment of newly diagnosed and recurrent glioblastoma
2007     NIHR Horizon Scanning Centre (NIHR HSC) Oral alitretinoin for adults with chronic hand eczema
2001     NIHR Horizon Scanning Centre (NIHR HSC) Oral and buccal insulin for diabetes - horizon scanning review
2008     NIHR Horizon Scanning Centre (NIHR HSC) Oral and inhaled treprostinil for pulmonary arterial hypertension: NYHA class III